IL6 and breast carcinoma: Mechanistically, the overexpression of COX-2 in TAMs activates the AKT pathway in breast cancer cells by releasing IL-6 and PGE2, thereby inducing the expression of MMP-9 and promoting EMT in breast cancer cells (101).